Medtronic Infuse Bone Graft Lawsuit Information: In 2002, the FDA granted Medtronic approval for its Infuse Bone Graft, a man-made bone growth product for limited use in the lumbar spine region. Despite this limited scope of approval, Medtronic, Inc. allegedly promoted off-label uses of the Infuse Bone Graft, including surgeries in the cervical spine, the thoracic spine, and also lateral and posterior approach of the lumbar spine. According to a recent New York Times article:

“Reports that doctors conducting medical trials while on Medtronic’s payroll may have hidden serious side effects for patients are deeply troubling,” Senator Baucus said in a statement. “We need to do everything we can to ensure companies aren’t concealing serious medical complications from patients just to increase profits,” he added. 

Off-Label Use of the Medtronic Infuse Bone Graft Linked to Injuries 

  • Severe swelling of the neck or throat
  • Excess bone growth in the spine
  • Chronic and severe pain in the legs or arms (inflammatory reaction)
  • Male infertility
  • Pancreatic, prostate, or breast cancer
  • Nerve damage
  • Death

Peterson & Associates, P.C. fights hard to make sure medical device companies take responsibility for the pain and suffering they cause. Get immediate legal assistance by calling us.

Post A Comment